Tracy Kemp

Tracy Kemp currently serves as the Vice President of Clinical Operations at QurAlis, a position held since November 2024. With a career spanning over two decades, Tracy has held various roles in clinical operations, including significant positions at organizations such as Vaxxinity, where Tracy was also Vice President of Clinical Development Operations from October 2020 to April 2024, and NewLink Genetics, overseeing clinical affairs related to the rVSV-ZEBOV Ebola vaccine in collaboration with Merck & Co. Previous experience includes leadership roles at Acambis, focusing on vaccine programs, and at Biogen as a Clinical Project Manager. Tracy began in the field as a Medical Writer at Genzyme and has a Master's in Public Health with a focus on Epidemiology Biostatistics from Boston University School of Public Health. Tracy's early work with the Peace Corps included contributions to health information systems and community health initiatives.